Lassa Fever Treatment Market size is expected to cross USD 480 Million by the end of 2036, expanding around 13% CAGR during the forecast period i.e., 2024-2036. In the year 2023, the industry size of lassa fever treatment was around 24 Million. The growth of the market can be attributed to the growing cases of fever across the world is projected to promote market growth. According to the data by the World Health Organization (WHO), 1 in every 5 Lassa fever infections result in severe infection in organs. Moreover, in 80% of cases, no symptoms are reported. Symptoms can vary from mild symptoms, such as nausea, and vomiting, to severe symptoms, such as deafness, seizure, and coma. As per another report by the WHO, deafness occurs in 25% of the cases of Lassa fever.
In addition, there has been an increasing incidence of Lassa fever, backed by a lack of sanitation and proper healthcare facilities. The major cause of Lassa fever is the consumption of food or water contaminated with rodent urine or faces. According to the data by UNICEF, 5 out of 10 people did not have access to safe sanitation services, in 2020.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?